SmpA is a small outer-membrane lipoprotein that is a component of the essential YaeT outer-membrane protein assembly complex. In Salmonella enterica serovar Typhimurium (S. Typhimurium), expression of the smpA gene was shown to be directed by two promoters, smpAp1 and smpAp2. The more distal promoter, smpAp1, is dependent upon the extracytoplasmic stress response sigma factor sigma(E). An smpA null mutant was constructed in S. Typhimurium SL1344 and was shown to be more sensitive than its wild-type parent to growth at high temperature and in the presence of sodium cholate, SDS plus EDTA, and the hydrophobic antibiotic rifampicin. The lack of SmpA in S. Typhimurium elicits a sigma(E)-dependent stress response. These findings are indicative of altered outer-membrane integrity in the smpA mutant, probably due to a defect in outer-membrane protein biogenesis. SmpA was not important for entry or survival within murine macrophages; however, the S. Typhimurium smpA mutant was attenuated in mice by both the oral and parenteral routes of infection, and SmpA appeared to be most important for the growth of S. Typhimurium at systemic sites.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1099/mic.0.2007/011999-0 | DOI Listing |
Food Sci Nutr
October 2024
Department of Food Science and Technology, School of Public Health Shahid Sadoughi University of Medical Sciences Yazd Iran.
The objective was to develop an active chitosan-based coating and to evaluate its effect on the shelf life and microbial safety of bread. Bacterial cellulose nanofibers (BCNF) and various levels (0.5%, 1%, and 2%) of silver nanoparticles (AgNPs) were in the chitosan (CS) film.
View Article and Find Full Text PDFLangmuir
October 2024
Research Center of Resource Chemistry and Energy Materials, Key Laboratory of Clay Minerals of Gansu, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, P.R. China.
5G radomes are easily wetted and stained by rainfall, which greatly reduces the quality of signal transmission. Superhydrophobic coatings are expected to solve this problem because of their unique wettability, but it is still challenging to develop robust superhydrophobic coatings via simple methods. Here, we report the design of robust superhydrophobic coatings containing oxalic acid-modified attapulgite (MDP) for inhibiting rain attenuation of 5G radomes.
View Article and Find Full Text PDFPlast Reconstr Surg
December 2024
From the Section of Plastic Surgery, Department of Surgery, University of Michigan Medical School.
Background: Silicone metacarpophalangeal (MCP) joint arthroplasty (SMPA) can reconstruct MCP joint deformities in the rheumatoid hand, but patient selection criteria for the procedure remains unclear. The authors used statistical learning to elucidate patient selection criteria that will enhance long-term patient-reported and functional outcomes in patients with severe hand rheumatoid arthritis (RA).
Methods: This was a secondary analysis of a prospective study of 169 adults with severe hand RA (average combined ulnar deviation and extensor lag at the MCP joint ≥50 degrees, per finger) with 1-year follow-up, conducted at 3 centers in the United States and England from January 1, 2004, to December 31, 2011.
Langmuir
April 2024
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
Superhydrophobic coatings hold immense promise for various applications. However, their practical use is currently hindered by issues such as poor stability, high costs, and complex preparation processes. Here, we present the preparation of cost-effective and stable superhydrophobic coatings through fluorination of natural attapulgite (F-ATP) nanorods and subsequent solvent-induced phase separation of a silicone-modified polyester adhesive (SMPA) with the F-ATP nanorods dispersed in it.
View Article and Find Full Text PDFPharmacol Res Perspect
April 2024
Sumitomo Pharma America, Inc, Cambridge, Massachusetts, USA.
Ulotaront (SEP-363856) is a TAAR1 agonist, with 5-HT1A agonist activity, currently in clinical development for the treatment of schizophrenia. In vitro studies indicate ulotaront is an OCT2-specific inhibitor with IC of 1.27 μM.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!